We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Swallowable Capsule Could Transform Detection of Gastrointestinal Diseases

By HospiMedica International staff writers
Posted on 21 Mar 2024

The conventional method for examining the intestines for gastrointestinal diseases involves an endoscopy, which uses a camera on a tube to identify visible issues. More...

Capsule endoscopies, where patients swallow a capsule that sends images wirelessly, have marked a significant advancement. However, there is still no method to detect when the digestive tract is not working when it is not contracting and relaxing as it should when pushing waste along, and when there is no visible problem. Now, scientists have developed swallowable sensors to specifically identify gut movement problems, potentially revolutionizing the detection of gastrointestinal diseases and conditions.

A research team including scientists from the University of Birmingham (Birmingham, UK) has developed an ingestible capsule dotted with sensors that measure pressure within the gut to detect points of failure. Sized at 3 cm in length and 1 cm in diameter, the capsule is equipped with up to five ultra-thin sensors, each as thin as one or two human hairs. These pressure sensors are capable of monitoring the entire length of the gastrointestinal tract, about eight or nine meters, detecting zones of no movement, normal function, or unusual activity. Unlike traditional imaging, this capsule senses contractions as well as the amount of pressure exerted and identifies areas of inactivity.

Due to the number of sensors and flexibility, the device remains functional even if partially damaged. The scientists have ensured that the capsule does not harm the gut by using very thin sensors with a low-friction coating. They have also aimed to make the system both sustainable and cost-effective. This ingestible system can provide colorectal medical teams with unprecedented insight into a patient’s digestive tract movement or its absence. Although the system has been trialed in synthetic models and animals, it is anticipated that at least another five years of clinical trials will be required before this innovative product can be introduced to the market.

Related Links:
University of Birmingham


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Sling
GoComfort
New
Tracheostomy Tube
Portex BLUselect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.